Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Bilia AB publ
Mandate

Vinge has advised Bilia AB publ

December 05, 2016

Vinge has advised Bilia AB (publ), listed on NASDAQ Stockholm, in conjunction with a tap issue of MSEK 250 within the scope of its non-subordinated corporate bonds, with a maturity date in March 2021.

The issue was performed as an interest expense corresponding to STIBOR 3 months + 150 interest points up to maturity. In total, the new outstanding amount following the issue is MSEK 750.

Vinge’s team consisted of responsible advokat Yohanna Öhrnegård assisted by Lina André.

Related

Vinge advises SAGA Diagnostics AB on convertible note issue

 SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

 Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023

Vinge has advised private equity firm Stirling Square Capital Partners

 Vinge has advised private equity firm Stirling Square Capital Partners in connection with its acquisition of a majority stake in Infobric, a leading provider of software solutions for the construction industry, from Summa Equity.
September 22, 2023